Delivery Order 75N93018D00013-75N93020F00003
- Not listed
- This is a delivery order issued against a larger contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $435,767.78 award to Battelle Memorial Institute, a non-profit research and development organization, covers clinical and non-human primate sample testing for SARS-CoV-2 vaccine and other biological product candidates. The delivery order does not have a set-aside designation. Battelle...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Battelle Memorial Institute, a large nonprofit research and development organization. The contract, valued at $6,398,512.00, is for clinical sample testing of SARS-CoV-2 vaccine candidates. This is a cost-plus-fixed-fee type contract that will run through April 17, 2025. The contract has several subcontractors, including Integral...
- This is a $12,996,780.00 prime contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Battelle Memorial Institute. The contract supports the development of assays and reagents for coronavirus vaccines. It was issued as a cost-plus-fixed-fee delivery order under a larger NIAID contract, with no set-aside designation. Key subcontractors include Beckman Coulter, Inc., Meso Scale Diagnostics LLC, Fisher...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Battelle Memorial Institute, a large nonprofit research and development organization. The contract is for the "Evaluation of Clinical Samples from Influenza Clinical Trials" and has a ceiling value of $5,744,120.00. The contract is a Delivery Order under the NIAID's existing contract vehicle, with a Cost Plus Fixed Fee pricing structure. The contract...
- This is a delivery order task order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Battelle Memorial Institute, doing business as Battelle, with a value of $274,639. The task order is part of a larger $4,592,741.07 contract to provide evaluation and testing services for vaccines and other biologics for infectious diseases. The task order will fund preparedness activities for testing National Institute...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.6 million cost-plus-fixed-fee delivery order contract to Battelle Memorial Institute. The prime contractor will provide research and development services for biomedical and applied exploratory development related to evaluation and testing of vaccines and other biologics for infectious diseases. Two subcontractors, the University of Texas Medical Branch at...
- This is a delivery order (contract type: cost plus fixed fee) awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Battelle Memorial Institute, doing business as Battelle, for $2,026,616.68. The contract is for preparedness and testing services for NIAID priority vaccines, including neurovirulence and reproductive toxicology studies. This work supports the EVALUATION AND TESTING SERVICES (ETS) FOR...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Battelle Memorial Institute on September 17, 2021, with a ceiling value of $15.768 million for preparedness and testing of NIAID priority vaccines in general safety toxicology studies. Place of performance is Columbus, OH. The ultimate completion date is December 31, 2026. This is a cost-plus-fixed-fee delivery order issued under no set-aside. Service Contract Inventory data shows the order's labor footprint...
- This is a $8,643,989.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for research and development in the physical sciences. It does not have a set-aside designation. Battelle frequently serves as a prime contractor and subcontractor for the U.S. government,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $2,221,940.37 delivery order contract is for preparedness and testing of NIAID priority vaccines in general safety and toxicology studies. It does not have a set-aside designation. Battelle has subcontracted portions of the work to Envigo Global...
- 75N93018D00013Indefinite Delivery Contract
- 75N93018D00013-75N93020F00003Delivery Order
This is a delivery order contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization, for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against emerging infectious diseases including COVID-19 (SARS-CoV-2). The total ceiling value of the contract is $12,290,377.00. The contract is a cost-plus-fixed-fee type with an ultimate completion date of April 30, 2024. This award is not a set-aside contract. Battelle has engaged two subcontractors, Life Technologies Corporation and Bio-Rad Laboratories, Inc., to provide specialized laboratory instrumentation, reagents, and services in support of the testing efforts under this contract. The NIAID frequently partners with organizations like Battelle to conduct biomedical research and testing to support the development of medical countermeasures for emerging infectious disease threats.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases | NIAID-DMID-NIHAI2017087 | Department of Health and Human Services National Institutes of Health | Solicitation 2/3 | 5/15/17, 9:56 AM | |
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases | NIAID-DMID-NIHAI2017087 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/3 | 2/6/17, 9:13 AM | |
Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases | NIAID-DMID-NIHAI2017087 | Department of Health and Human Services National Institutes of Health | Award Notice 3/3 | 9/13/18, 1:53 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $1.1m | 12/2/20 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 11/10/20 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 6/10/20 | |
| Not listed | Not listed | $2.4m | 4/21/20 |